DOW JONES23,201.07+547.21 2.42%
S&P 5002,719.54+60.13 2.26%
NASDAQ8,040.01+152.75 1.94%

JP Morgan Maintains Overweight on ChemoCentryx, Raises Price Target to $61

JP Morgan maintains ChemoCentryx (NASDAQ:CCXI) with a Overweight and raises the price target from $60 to $61.

Benzinga · 03/11/2020 14:19

JP Morgan maintains ChemoCentryx (NASDAQ:CCXI) with a Overweight and raises the price target from $60 to $61.